The present invention provides novel sulfoximine compounds, compositions comprising these compounds and methods of using these compounds as inhibitors of CYP24. In particular, the compounds of the invention are useful for treating diseases which benefit from a modulation of the levels of 1α,25-dihydroxy vitamin D3, for example, cell-proliferative disorders.
本发明提供了新型亚砜胺化合物,包括这些化合物的组合物以及使用这些化合物作为CYP24
抑制剂的方法。特别是,本发明的化合物对于治疗受益于调节1α,25-二羟基
维生素D3
水平的疾病非常有用,例如细胞增殖性疾病。